Help shape GoConqr. What should we add next?

Flashcards

CHF, bacterial endocarditis, and pericarditis ACM

keliansherman201 English 110 cards

Petechiae Painless red intradermal hemorrhage Usually < 2mm May be seen most commonly on upper palate or extremities in…

Cards in this deck (110)

  1. 1Cardiac Output =Cardiac Output = Stroke Volume x Heart Rate
  2. 23 major determinants of Stroke Volume are:Preload
    Afterload
    Myocardial Contractility
  3. 3Cardiac Output is Matched by the body’s total __________needs.Cardiac Output is Matched by the body’s total metabolic needs.
  4. 4Preload: The more a normal ventricle is distended (filled with blood) during diastole, the greater the _____________the greater the volume
    of blood ejected during
    the next systolic contraction.
  5. 5AfterloadThe resistance a heart must overcome to empty it’s content
    e.g. BP
  6. 6Ventricular wall stress increases in response to:-the arterial systolic pressure (i.e. hypertension)
    -Increased chamber size (e.g. dilated heart chamber)
  7. 7An increase in wall thickness serves an initial compensatory role in reducing _____________.An increase in wall thickness serves an initial compensatory role in reducing wall stress.
    However...when if gets thicker the less blood it can hold =decreased SV
  8. 8Contractility =changes in the force generated by the myocardium for a given set of preload and afterload conditions.
  9. 93 Causes of Heart Failure (decreased Cardiac Output)1. Impaired ventricular filling (Decrease in Preload)
    2. Increased Afterload
    3. Impaired Contractility
  10. 10Stroke Volume rises when there is:-Increase in preload
    -Decrease in afterload (decrease things to push against)
    -Increased contractility
  11. 11Ratio of Systolic vs. Diastolic Ventricular Dysfunction2/3 of HF is Systolic Dysfunction
    1/3 is Diastolic
  12. 12EF normally =60%
  13. 13Ejection Fraction decreases withSystolic Dysfunction
  14. 14What will the EF be like with diastolic dysfunctionEF will be normal at about 60% with diastolic dysfunction but it can’t fill as much (due to thickened walls)
  15. 15Systolic dysfunction Cause:Impaired Contractility or excessive afterload
    Ventricles thinned, stretched, enlarged
  16. 16Decreased LVEF (<40-50%) with which dysfunctionSystolic dysfunction which leads to:
    Decreased output
    Fluid retention (edema)
    Left - Pulmonary
    Right - Systemic
  17. 17Diastolic dysfunction Cause:Decreased filling
    Ventricles stiff/cannot relax
  18. 18Normal left ventricular ejection fraction (> 50%) seen with what dysfuncitonDiastolic dysfunction
  19. 19Diastolic dysfunction leads toCardiac output limited during exertion (cannot take in larger volume in ventricle)
  20. 20aortic stenosis, and uncontrolled hypertension (which type HF)systolic dysfunction
    (increased afterload causes aka
    pressure overload)
  21. 21MI, transient myocardial ischemia, chronic volume overload (mitral and aortic regurgitation) and dialated cardiomyopathy lead to which type of HF..Systolic dysfunction due to impaired
    contractility
  22. 22mitral stenosis and pericardial constriction or tamponade cause which type of HF?diastolic dysfunction due to obstruction
    of left ventricular filling
  23. 23left ventricular hypertrophy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and transcient myocardial ischemia lead to which type of HF?Diastolic dysfunction caused by impaired
    ventricular relaxation
  24. 24Right Ventricle is thinner / highly compliant as it ejects against a low pulmonary vascular resistance.Very susceptible with sudden increases in afterload (e.g. PE)
    Isolated Right HF is rare (called cor pulmonale)
  25. 25Most common cause of Right HF is…Left HF
  26. 26left sided heart failure presentationDyspnea, Orthopnea, Paroxysmal Nocturnal Dyspnea(PND), Nocturnal Cough
  27. 27right sided heart failure presentationPeripheral Edema, RUQ Discomfort / hepatic enlargement
  28. 28Cycle of chronic heart failure-Increased BP and CO
    -increased cardiac workload
    -left ventricular dysfunction
    -decreased CO and BP
    -hemodynamic remodeling and neurohormonal activation
    -increased HR, contractility, constriction, and increased volume
  29. 29Compensatory Mechanisms-ALL in response to decreased BP
    BP = CO x TPR (total peripheral resistance)
    -Neurohormonal Mechanisms (increase TPR)
    Sympathetic Nervous System (Adrenergic mechanisms)
    RAA system
    Increased ADH
    All Result in salt and water retention therefo
  30. 30Decreased CO= Decreased Perfusion pressure to baroreceptors in the heart (low BP)
  31. 31Increased COIncreased heart rate (B-adrenergic stim.)
    contractility
  32. 32Increased TPRVasoconstriction 2/2 alpha receptors
  33. 33Excess norepinephrineExcess norepinephrine “toxic” to myocyte
  34. 34Decreased CO= Decreased Perfusion pressure to juxtaglomerular cells / macula densa of the kidney
    Increased Renin Release
    Increased ADH (Vasopressin)
  35. 35ANP/BNP produced and stored bymyocytes
  36. 36ANP/BNP Released in response-Released in response to atrial/ventricular distension (stretch), Angiotensin II and NE stimulation.
    -Increased levels of BNP measured during hypervolemic states (e.g. HF)
  37. 37BNP = Released by ventricles after-volume expansion
    and pressure overload
  38. 38Elevated BNP is associated withReduced LVEF, LVH,
    elevated LV filling Pressures, Acute MI, PE and COPD.
  39. 39ANP/BNP are counter-regulatory for theRAA system
  40. 40Elevated BNP Lends support to a suspected diagnosis of HF butshould not be used in isolation to confirm or exclude the presence of HF.
  41. 41A sustained increase in wall stress stimulates the development ofmyocardial hypertrophy and deposition of extracellular matrix which maintains contractile force
    -Caused by chronic volume / pressure overload
    Wall thickness increases
    Fibrosis / Stiffening
    Loss of Myocytes
  42. 42Ventricular Hypertrophy and remodelingComes at the expense of higher Diastolic ventricular pressures which are transmitted to the left atria and pulmonary vasculature.
  43. 43CHF Patients present in one of 3 ways1. Decreased Exercise Tolerance (Fatigue)
    2. Syndrome of Fluid Retention
    3. NO symptoms
    (i.e. incidental discovery found to have cardiac enlargement or dysfunction)
  44. 44Physical Exam right sided :-JVD
    -Hepatomegaly
    -Peripheral Edema
  45. 45Physical Exam left sided:Tachycardia, Tachypnea, dyspnea, orthopnea, PND
    Pulmonary Rales (Crackles) = Fluid at the Alveolar Level
    Pneumonia or CHF
    S3 Gallop
  46. 46the main tool of heart failure is...Echocardiography
  47. 47Echocardiography3 Basic Questions:
    Is the LVEF preserved or reduced? (55-75%)
    Is the structure of the LV normal or abnormal? (Size, Wall Thickness, and Motion)
    Are there other structural abnormalities (such as valvular, Pericardial, Or right ventricular abnormalities) that could explain the clinical presentation?
    Baseline for comparison
    Severity of structural remodeling
    Repeat assessment of LVEF may be helpful with a major change in clinical status.
  48. 48Labs – to reveal the presence of conditions that can lead or exacerbate HFElectrolytes (kidney fxn)
    Renal Function
    CBC (rule out infections)
    UA (kidney fxn)
    A1C (risk factor)
    Lipid Panel (risk factor)
    Hepatic Function (due to hepatomegaly)
    Thyroid Function (fatigue, wt gain)
    Transferretin (hemochromotosis)
    HIV (HIV cardiomyopathy)
    *Rare Cardiac Catheterization
    If Angina or suspected CAD
  49. 49CXR of CHF:Cardiomegaly with diffuse pulmonary infiltrate consistent with pulmonary edema.
    or normal
  50. 50Risk factors for heart failure (all can cause remodeling)HTN
    Valvular Heart Disease
    Diabetes
    Myocardial infarction
    Atherosclerosis
    Cardiomyopathy
    Arrhythmias and LBBB
    COPD (increase hr) V/q mismatch
    Cardiotoxic drugs (smoking, alcohol, cocaine, ephedra, NSAIDs)
  51. 51ACE-I / ARB (ACE=prils and ARB=sartans)Inhibits remodeling
  52. 52Beta-BlockersCounters effect of SNS
    Must if post MI (inhibits remodeling)
    Atenolol / Metoprolol (Beta-1 selective)
    Carvedilol (non-selective, but can decrease remodeling) & Labetolol (potent Vasodilator) Can Exacerbate HF
    Start Low, Go Slow**
  53. 53Three Classes of drugs can exacerbate the syndrome of HF and should be avoided:Antiarrhythmic agents
    CCB’s (calcium channel blockers)
    NSAID’s (Na retention, peripheral vasoconstriction)
  54. 54Stage C/D Pharmacologic TherapyDiuretics: (3rd lines)
    HCTZ (hydrocorathyizide?)
    Aldosterone blockers
    Spironolactone
    Digoxin
    positive inotropic effect (use in Afib)
    neurohormonal effects (dec. renin and NE at low doses)
  55. 55When to refer:Stage C
    Conduction abnormality (any blocks)
    Suspect prior/unknown MI
    Suspect CAD
    Evidence of pulmonary hypertension
  56. 56Other TherapiesNon-pharmacologic Therapies
    Implantable Cardioverter / Defibrillator
    Non ischemic cardiomyopathy
    LVEF <35%
    Treatment of Arrhythmias (QRS >0.12s)
    Cardiac Resynchronization
    Revascularization for Ischemia
  57. 57Acute Pulmonary Edema treatmentLMNOP
    Lasix, Morphine, Nitrates (pressors), Oxygen, Position
  58. 58Home monitoring / ManagementPreventing Acute exacerbations / Hospitalizations and Improving QUALITY of life
    Education of Patient and Family members
    Recognition of warning signs of worsening function (edema)
    Weight should be monitored daily
    Understanding of Med Regimens
    Diet Adjustment
    Salt / sodium Restriction (<2000mg QD)
    Promote Moderate Physical Activity if tolerated
    Infections: PVax / Influenza Vaccination
  59. 59ConclusionsHF is progressive and dynamic
    Early treatment can slow progression or reverse staging
    Early prevention – risk factor modifications
    Decrease morbidity and lower hospitalizations
    Mortality rates not changing but quality of life can be improved
  60. 60Describe the epidemiology of bacterial endocarditis?Once a disease affecting young adults with previously well‐identified valve disease mostly rheumatic disease— is now affecting older patients, most without known valve disease and develop BE as the result of healthcare associated procedures
  61. 61high-risk groups and predisposing factors for bacterial endocarditis-Abnormal cardiac structure
    -Abnormal risk of bacteremia
    -Age > 60 years
  62. 62typical pathogens associated with bacterial endocarditis in all patientsStaphylococcus Aureus 32%
    Streptococcus Viridans 18%
    11% Enterococcus
    11% Coagulase-negative staphylococcus
    8% S. Gallolyticus
    4% gram neg rods
    10% culture neg
    2% fungus
  63. 63classic presentation of acute bacterial endocarditis, symptoms (S. Aureus)Abrupt onset: high fever, chills, night sweats
    Prominent leukocytosis
    Rapid, severe valve destruction
    Apical Heart murmur (not always in R-sided)
    Often complicated by heart failure
  64. 64bacterial endocarditis physical exam findingsConstitutional -Fever
    Cardiovascular -Murmur, CHF signs
    GI - Splenomegaly, Abdominal Tenderness to palpation (TTP)
    Neuro - neurologic signs, Roth spots on funduscopic exam
    Musc. - bony TTP, or septic looking jt
  65. 65principles of an appropriate labs for and diagnosis of endocarditisBlood cultures x 3 sets (minimum) prior to giving antibiotics.
    CBC – leukocytosis (ABE), normocytic anemia
    ESR – elevated, often over 100
    Creatinine – assure renal fx’n preserved
    Urinalysis- microscopic hematuria, glomerulonephritis (proteinuria, RBC casts)
    EKG – evaluate for conduction defects on admission and regularly, thereafter.
    Echocardiogram
  66. 66the Modified Duke Criteria for bacterial endocarditis major criteria1. Sustained bacteremia (3/4 sets 1 hr apart OR 2 sets 12 hours apart) by potentially causative organism
    2. Endocardial involvement
    Vegetation (oscillating intracardiac mass), valve abscess/perf’n, prosthetic dehiscence
    OR
    New Valvular regurgitation
  67. 67management for bacterial endocarditisGet 3 sets of blood cultures before starting Rx!
    Native Valve ABE empiric therapy
    Nafcillin/Gentamicin OR Vancomycin/Gent
    Native Valve SBE (consider waiting for cx results before empiric rx if pt stable)
    Ampicillin/Gentamicin (strep coverage)
    Prosthetic Valve: Vanco/Gent/Rifampin
    Rifampin improves tissue penetration
  68. 68Counsel patients on appropriate prophylaxis for endocarditisGive amoxicillin (clindamycin if pcn-allergic) prior to dental procedures for at-risk pts
    Congenital Cyanotic Heart Disease
    Unrepaired or repaired with residual defects
    Prosthetic valve
    Prior endocarditis hx
    “Valvulopathy” of heart transplant
    No longer prophylax MR/AS/AI
  69. 69Describe the classic presentation of pericarditisPositional Pleuritic Chest Pain
    Better leaning forward, worse supine
    May radiate to trapezius muscles of upper back
    Fever
    Pericardial Friction Rub
  70. 70pericarditis ECG findingsDiffuse ST elevation, precordial PR depr’n
    Important to differentiate from Acute MI
  71. 71work up of pericarditis**≥ 2 of following 4 findings for dx:
    Chest pain
    Pericardial friction rub
    Appropriate ECG changes
    Pericardial Effusion
    Presence of pericardial effusion is NOT required for dx
  72. 72treatment of pericarditisEKG
    Labs: Thyroid testing ,Renal function (Creatinine), ANA, RF
    Consider TB/fungal
    Consider evaluation for recent MI (e.g., wall motion abnormalities by ECHO, troponin less helpful because often ↑ in pericarditis)
  73. 73Bacterial Endocarditis definitionInfection of the endothelial lining of the heart (including, but not limited to the valves)
  74. 74Acute Bacterial Endocarditis (ABE)is infection of normal or abnormal valves with a virulent organism (e.g., Staphylococcus Aureus)
  75. 75Subacute Bacterial Endocarditis (SBE)indolent infection of abnormal valves with a less virulent organism (e.g., Streptococcus Viridans)
  76. 76Incidence of bacterial endocarditis10,000-15,000 cases/yr in USA
    3.2 to 11.6 cases/100,000 person-yr
  77. 77High risk group for BE (heart defects) (3/4 of cases)Congenital Heart Disease
    Abnormal cardiac valves
    Prosthetic valve
    Mitral Valve Regurgitation
    Aortic Stenosis/Regurgitation
    Indwelling pacemaker lead
  78. 78High risk group for BE (abnormal risk of bacteremia)IV drug use (IVDU)
    Indwelling central venous catheter
    Chronic hemodialysis
    Poor Dentition/Dental Caries
    Colon CA/Inflammatory Bowel Disease
  79. 79Colon CA/Inflammatory Bowel Disease: ↑ risk of_____ (abnormal bacteremia risk)↑ risk of Streptococcus Gallolyticus (formely S.Bovis) bacteremia
  80. 80Bacterial endocarditis Infection in IV Drug Users (Right or left)IVDU is risk factor for R-sided endocarditis, but L-sided endocarditis still more common than R-sided endocarditis in IVDU
  81. 81typical pathogens associated with bacterial endocarditis prosthetic valve30-35% S. Epidermidis (usually non-pathologic skin flora)
    5-10% Fungus and Diphtheroids
  82. 82HACEK causes of Endocarditis (The GNRs cause <0.005% of BE cases)Haemophilus species
    Aggregatibacter (formerly Actinobacillus actinomycete comitants)
    Cardiobacterium hominis
    Eikenella species
    Kingella kingae
  83. 83Endocarditis Pathogens IVDU or Prosthetic valves60% Staphylococcus Aureus
    20% Streptococcus Viridans
    10% Gram-negative (esp. salmonella, serratia)
  84. 84classic presentation of subacute bacterial endocarditis, symptoms (S.Viridans)Indolent onset: fever, night sweats, weight loss
    Apical Heart murmur (not always in R-sided)
    Minor endocardial damage
    Leukocytosis often minimal or not present
  85. 85BE presentation Right-sided valve involvement (tricuspid >> pulmonic)Cardiovascular – Congestive Heart Failure (CHF), heart block
    Hematologic (elevated ESR, leukocytosis, anemia, positive RF/ANA)
    Pulmonary (Abscesses in Right-sided)
  86. 86BE presentation Left-sided valve involvement (mitral, aortic)Cardiovascular – Congestive Heart Failure (CHF), heart block, mycotic aneurysms
    Hematologic (elevated ESR, leukocytosis, anemia, positive RF/ANA)
    Derm (manifestations of emboli)
    GI (Splenic infarct, Mesenteric infarct)
    Neuro (Roth spots, Mycotic aneurysm, stroke, encephalitis/abscess/meningitis)
    Musc. (Septic arthrits, osteomyelitis)
    Renal (Infectious glomerulonephritis, infarcts)
  87. 87Symptoms suggestive of endocarditisFever
    Night Sweats
    Malaise/Weakness? Both
    Weight Loss
    Shortness of Breath
    Abdominal pain ( infarct)
    Rashes/skin changes
    Arthralgias/bone pain
  88. 88Endocarditis – Derm examPetechiae – esp on soft palate
    Roth’s spots- retinal hemorrhage, pale center
    Osler’s Nodes
    Janeway Lesions: purple-red painless lesions on palms/soles
    Splinter Hemorrhages
  89. 89—Petechiae
    Painless red intradermal hemorrhage
    Usually < 2mm
    May be seen most commonly on upper palate or extremities in endocarditis
    Petechiae Painless red intradermal hemorrhage Usually < 2mm May be seen most commonly on upper palate or extremities in endocarditis
  90. 90—Janeway Lesions
    Non-tender erythematous or hemorrhagic macular or nodular lesions on palms/soles
    May ulcerate
    Causative organisms may be cultured if ulcerated
    (bacteria lodged in skin)
    Janeway Lesions Non-tender erythematous or hemorrhagic macular or nodular lesions on palms/soles May ulcerate Causative organisms may be ...
  91. 91—Osler’s Node
    Painful, immune complex-related inflammatory nodules on finger pads
    Occur in 25% of SBE, rare in ABE
    Osler’s Node Painful, immune complex-related inflammatory nodules on finger pads Occur in 25% of SBE, rare in ABE
  92. 92—Splinter Hemorrhage
    Linear, red hemorrhages in nails
    If present in proximal 1/3 of nail bed, stronger likelihood they’re non-traumatic
    More common in SBE
    Splinter Hemorrhage Linear, red hemorrhages in nails If present in proximal 1/3 of nail bed, stronger likelihood they’re non-traumatic Mo...
  93. 93—Roth Spots
    Retinal hemorrhage around the area of ischemia (cotton wool=pale)
    Roth Spots Retinal hemorrhage around the area of ischemia (cotton wool=pale)
  94. 94If endocarditis suspected based on history/physical /blood cultures:Trans-thoracic Echocardiogram - 34% positive for vegetation on valve (if neg move to the one below)
    Trans-esophageal echocardiogram- 81.4% positive for vegetation on valve
  95. 95the Modified Duke Criteria for bacterial endocarditis minor criteriaPredisposing medical condition
    Fever (>38°C)
    Vascular phenomena (septic emboli, mycotic aneurysm, janeway)
    Immune phenomena (glomerulonephritis, Osler’s nodes, Roth spots, RF+)
    Blood cx + (not major) or serologic evidence of infx’n
  96. 96Diagnosis by Modified Duke Criteria for Infectious EndocarditisDefinite pathologic: Micro-organism demonstrated in vegetation or cardiac abscess OR pathology of vegetation shows active endocarditis
    Definite clinical: 2 major, OR 1 major/3 minor, OR 5 minor criteria
    Possible: 1 major/1 minor OR 3 minor
  97. 97management for bacterial endocarditis culture guidedMethicillin-sensitive S.Aureus: Oxacillin or Nafcillin
    Methicillin-resistant S. Aureus: Vancomycin, often with Rifampin to help eradicate
    S.Viridans/Bovis- Penicillin G
    Enterococcus- Ampicillin/Gentamicin
    HACEK organisms: Ceftriaxone
    ** 6 weeks of IV antibiotics is standard to allow full eradication of bacteria.
  98. 98Endocarditis – Surgical IndicationsIncompetent Valve causing CHF despite maximal medical therapy
    Heart Block worsening (due to conduction system involvement)
    Cardiac Abscess (need drained)
    Recurrent emboli on medical therapy
    Fungal infection (harder to get rid of)
  99. 99Endocarditis – Management PearlsAnticoagulation with heparin/coumadin is ***contra-indicated due to potential for hemorrhage from emboli
    Anticoagulation generally accepted despite ↑ risk in certain conditions:
    Prosthetic heart valve
    Acute coronary syndrome
  100. 100Describe the classic presentation of pericarditis with pericardial effusionDistant heart sounds
    Fainter rub
    Dullness over left posterior lung field (Ewart’s sign)
  101. 101Pericarditis - Treatment Caveat: if immediate post-MI period continue aspirin/heparin unlessAvoid anticoagulation, cardiac tamponade
    sx develop
    NSAIDs
    Colchicine or Steroids (if NSAIDs ineffective)
  102. 102Pericarditis - Treatment Caveat: if immediate post-MI period continue aspirin/heparin unlesspericardial effusion > 1 cm or tamponade
    sx develop
  103. 103Complications of PericarditisCardiac Tamponade
  104. 104Cardiac tamponade Occurs in up to 10-15% of acute pericarditis**medical emergency
    Pericardial pressure reaches 20-24 mm Hg and causes elevated right atrial pressure which exceeds venous return capacity
    Low Blood Pressure
    Elevated Jugular Venous Pressure
    Pulsus Paradoxus present
    Treat by draining pericardial space
  105. 105Constrictive Pericarditiscauses fibrosis and scar
    Most common causes
    TB (world-wide)
    Idiopathic, thought due to prior acute pericarditis (USA)
    Post mediastinal XRT (Hodgkin’s, Breast CA)
    Prior cardiac surgery
  106. 106Constrictive Pericarditis SymptomsRight heart failure (edema, hepatic vascular congestion)
    Left heart failure develops later (dyspnea, cough, orthopnea/PND)
  107. 107Constrictive Pericarditis SignsNormal BP
    Elevated Jugular Venous Pressure
    Kussmaul’s Sign (inspiratory ↑JVP as diaphragm displaces blood from engorged splanchnic veins)
    Pericardial Knock (early diastole, sudden ↓ filling as constrictive pericarditis ↓ venous return )
  108. 108Constrictive Pericarditis – DxCXR – may show eggshell calcifications
    EKG – No specific findings
    Echocardiogram – May show calcified and thickened pericardium, preserved LV Fx’n
    Right and Left Heart Catheterization
    Show near-equalization of diastolic pressure in all four chambers (within 5 mm Hg)
    “square-root” pressure dip/plateau in RV and LV diastole
  109. 109Constrictive Pericarditis - RxComplete pericardial resection
    Outcome is poor if patients have shortness of breath at rest (NYHA Class IV), and surgery not recommended in these patients.
  110. 110Pericarditis - Etiology***Non-infectious (68%)
    (Neoplastic (35%)
    Immune-mediated (23%))
    ***Infectious (31%)
    -Viral (21%), Non-TB Bacterial (6%),
    TB (4%), Fungal (<1%)

Information

Description
Flashcards on CHF, bacterial endocarditis, and pericarditis ACM, created by keliansherman201 on 01/11/2015.
Views
6
Rating

Feedback

What is it about?

What should we add next?